20/20 GeneSystems
Artificial intelligence-powered diagnostics for cancer & COVID-19
Overview
Raised: $3,792,229
Rolling Commitments ($USD)
10/31/2020
$4,699
1,710
2000
Healthcare & Pharmaceuticals
HealthTech
Rockville, Maryland
Raise History
Offering Name | Close Date | Platform | Valuation/Cap | Total Raised | Security Type | Status | Reg Type |
---|---|---|---|---|---|---|---|
20/20 GeneSystems | 12/20/2022 | StartEngine | $58,400,000 | $232,704 | Convertible Note | Funded | RegCF |
20/20 GeneSystems | 06/26/2021 | StartEngine | $38,500,000 | $2,903,017 | Equity - Preferred | Funded | RegA+ |
20/20 GeneSystems | 10/31/2020 | SeedInvest | $38,500,000 | $3,792,229 | Equity - Preferred | Funded | RegA+ |
20/20 GeneSystems | 12/13/2017 | Microventures | $23,000,000 | $1,064,807 | Equity - Preferred | Funded | RegCF |
Price per Share History
Note: Share prices shown in earlier rounds may not be indicative of any stock splits.
Valuation History
Revenue History
Note: Revenue data points reflect the latest of either the most recent fiscal year's financials, or updated revenues directly from the founder, at each raise's close date.
Employee History
Upgrade to gain access
-
$25 /month
billed annually - Free portfolio tracking, data-driven ratings, AI analysis and reports
- Plan Includes:
- Everything in Free, plus
- Company specific KingsCrowd ratings and analyst reports
- Deal explorer and side-by-side comparison
- Startup exit and failure tracking
- Startup market filters and historical industry data
- Advanced company search ( with ratings)
- Get Edge Annual